(Date:11/24/2009)... Health care employment grew by... only one to show consistent growth during the U.S...als remain in trouble, and health systems are comi...nel, instead of just administrators. , ...care employment continued growing in October despi...
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire-Fir...pharmaceutical company focused on developing and c...nounced today that Anthony DiTonno, President and ...t the 21st Annual Piper Jaffray Health Care Confer...k Palace Hotel in New York, New York. ,, Mr. D...
(Date:11/24/2009)... The FBI recently approved the Pr...es participating in or generating DNA records for ... Madison, WI USA (PRWEB) -- The FBI recentl...m for use by laboratories participating in, or ge...ystem (NDIS). NDIS currently contains more than se...
(Date:11/24/2009)..., DUBLIN, November 24 /PRNewswire-FirstCall...obal specialty biopharmaceutical company, today,an...n Medicines Agency for,velaglucerase alfa, the com...or the treatment of Type 1 Gaucher disease. This i...e alfa that has been submitted, with previous,subm...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4...DELHI, August 21 Omaxe Infrastructure &,Construct...of Omaxe Ltd has,received a Letter of Intent for t...Associated Hospital at Saharanpur, UP from UP Gove...the project is Rs250 crores,approx., The project ...t up area,of 15.66 lac sq ft. It will comprise of ...
...GHAI, China, Aug. 21 /Xinhua-PRNewswire-FirstCall/... ("China-Biotics," "the,Company"), a leading Chine...development, marketing and distribution of probiot...contract with Henan Square,Pharmaceutical Co., Ltd...or,Square Pharmaceutical,s probiotics-based medici...
...h Quarter revenues of $22.0M increased 29% and adj...reased 218% -, - Total Fiscal Year Revenues of $79... $0.99 increased 87% -, EXTON, Pa., A...oday reported the results for its fourth quarter a...er Results, Revenues: Sales and Royalties. Total ...
Other Biology Technology:Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores 2China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base 2China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base 3Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 2Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 3Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 4Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 5Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 6Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 7Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 8Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 9Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 10Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 11Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 12Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 13Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 14Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 15Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 16Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 17Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 18Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 19Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 20Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 21...first large, single-institution series directly co...ts, researchers from the University of Chicago fou...oduced substantially better weight-loss outcomes t...bypass. , In the October issue of the Annals of S...witch (DS) produced greater weight loss than the R...
...nt years, health professionals and the general pub... ravages that could result from a flu pandemic. Al...s of 1968 and 1957, it is the infamous 1918-1920 p...at scale--that causes the most trepidation. , S... many people died from this particular strain of t...
...hers have discovered that even a small amount of M...e brain, according to the first study to look at t...onal drug in new ecstasy users. The findings were ...logical Society of North America (RSNA). , “We fou...f the brain in young adults who just started to us...
Other Biology News:For super-obese patients, duodenal switch beats gastric bypass 2For super-obese patients, duodenal switch beats gastric bypass 3Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 3Ecstasy can harm the brains of first-time users 2Cytidine 5-Triphosphate, Sodium (CTP) from GE Healthcare, formerly Amersham Biosciences
... Blotting Reagent Pack, 1. Contains reagents for ...ane-bound mouse and rabbit primary antibodies. Des...s. Detection reagents are not included, but the sy...: Blotting & Labeling & Detection, Protein Labelin...
...LVF-UV-HL, LVF-CUV-ADP, FHS-LVF and CVD-Diffuse W...Linear Variable Filters to create the world's firs...h and adjustable bandpass. Each filter features an...and (99.8%). These filters -- with interference c...
Silencer Validated siRNA 5 nmol from Ambion
Biology Products: